菱山優智綜合錠狀食品
菱山優智綜合錠狀食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 1110612621
- Chinese name
- 菱山優智綜合錠狀食品
- English name
- NEW HISHIYAMA EXP TABLETS
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 德效國際有限公司
- Registration date
- 2022-12-21
- Published validity end
- 2027-12-21
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CASEIN CALCIUM | CASEIN CALCIUM | Calcium |
| D-LACTOSE | D-LACTOSE | Not identified |
| SOY PROTEIN POWDER | SOY PROTEIN POWDER | Not identified |
| ORANGE FLAVOR | ORANGE FLAVOR | Not identified |
| VITAMIN C (ASCORBIC ACID) | VITAMIN C (ASCORBIC ACID) | Vitamine C |
| VITAMIN B1 (THIAMINE MONONITRATE) | VITAMIN B1 (THIAMINE MONONITRATE) | Vitamine B1 (thiamine) |
| VITAMIN B2 (RIBOFLAVIN) | VITAMIN B2 (RIBOFLAVIN) | Vitamine B2 (riboflavine) |
| VITAMIN B6 (PYRIDOXINE HCL) | VITAMIN B6 (PYRIDOXINE HCL) | Vitamine B6 |
| VITAMIN B12 (CYANOCOBALAMIN) | VITAMIN B12 (CYANOCOBALAMIN) | Vitamine B12 |
| FRUCTOOLIGOSACCHARIDES | FRUCTOOLIGOSACCHARIDES | Not identified |
| CHITOSAN | CHITOSAN | Chitosan |
| CRYPTHECODINIUM COHNII | CRYPTHECODINIUM COHNII | Not identified |
| BETA-CAROTENE | BETA-CAROTENE | Bêta-carotène |
| BIFIDOBACTERIUM LACTIS | BIFIDOBACTERIUM LACTIS | Not identified |
| VITAMIN D3 (CHOLECALCIFEROL) | VITAMIN D3 (CHOLECALCIFEROL) | Vitamine D |
| MICROCRYSTALLINE CELLULOSE | MICROCRYSTALLINE CELLULOSE | Not identified |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | Not identified |
| STEARIC ACID | STEARIC ACID | Acide stéarique |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| BEET RED COLOR | BEET RED COLOR | Not identified |
| SAFFLOWER YELLOW COLOR | SAFFLOWER YELLOW COLOR | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 菱山優智綜合錠狀食品
- Active ingredients
- CASEIN CALCIUM;;D-LACTOSE;;SOY PROTEIN POWDER;;ORANGE FLAVOR;;VITAMIN C (ASCORBIC ACID);;VITAMIN B1 (THIAMINE MONONITRATE);;VITAMIN B2 (RIBOFLAVIN);;VITAMIN B6 (PYRIDOXINE HCL);;VITAMIN B12 (CYANOCOBALAMIN);;FRUCTOOLIGOSACCHARIDES;;CHITOSAN;;CRYPTHECODINIUM COHNII;;BETA-CAROTENE;;BIFIDOBACTERIUM LACTIS;;VITAMIN D3 (CHOLECALCIFEROL);;MICROCRYSTALLINE CELLULOSE;;MAGNESIUM STEARATE;;STEARIC ACID;;TITANIUM DIOXIDE;;BEET RED COLOR;;SAFFLOWER YELLOW COLOR;;
- Valid until
- 1161221
- Registration number
- 1110612621
- Licence holder
- 德效國際有限公司
- Registration date
- 1111221
- Published reference
- DHC0B106126216
- Published English name
- NEW HISHIYAMA EXP TABLETS
Official source
View the official register, number 1110612621
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- CHITOSAN
Read the warning, when it applies and the studies cited
CHITOSAN
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Pittler et al. 1999).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products (except for weight management).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Weight management.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Contraindications
Condition of application: All products.
Do not use if you have an allergy to seafood.
Condition of application: Weight management.
Do not use if you are pregnant (HC 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Moraru et al. 2018; Mhurchu et al. 2004; Pittler et al. 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- VITAMIN D3 (CHOLECALCIFEROL)
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.